Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4538_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
26 Мб
Скачать
388
https://t.me/medicina_free
resolutions of N-acetyl aspartate (NAA), choline (Cho), creatine (Cre), and myo­inositol (mI) metabolites have been examined.
NAA, an amino-acid derivative, is primarily located in neurons and is thought to be a marker of neuronal viability. Reductions of NAA may reect neurodegenera­tion [46, 47]. Abnormal levels of Cho suggest inammation, cellularity, and mem­brane degradation associated with demyelination [48]. A decrease in the ratio of NAA to Cho has been utilized as an indicator of cerebral metabolic injury, such as gliosis and impairment of neuronal and axonal function [4951].
MRS is a useful neuroimaging tool for OSA study, because it provides a measure of cerebral metabolic change that may reect pathologic insults to brain integrity.
V. K. Paramasivan et al.
21.6.23 Functional Neuroimaging
Functional neuroimaging helps to examine cerebral activation in response to an external probe. fMRI images are generally acquired using the blood-oxygen-level­dependent (BOLD) technique. This noninvasive, high spatial and temporal resolu­tion technique enables the acquisition of images dependent on the MR signal’s sensitivity to excesses of cerebral blood ow associated with an increase of synaptic activity in the brain.
Functional neuroimaging techniques are ideal for investigating acute changes in the brain associated with the performance of various challenges like respiratory and cognitive. These neuroimaging ndings support the presence of OSA-associated neurofunctional and white-matter impairments, particularly in the frontal lobes and hippocampus. Such impairment is consistent with proposed models of the central nervous system and cognitive dysfunction in OSA implicating small vessel disease [52] and the prefrontal cortex [53].
21.7 Role ofUltrasound inIdentifying
theAirway Obstruction
Ultrasonography (USG) is increasingly being explored as a tool for evaluating upper airway anatomy and pathologic characteristics, with clinical use developing in areas as broad as the diagnosis of laryngeal and swallowing abnormalities, guid­ance for percutaneous tracheostomy and cricothyrotomy, and also in sleep apnea.
The use of conventional ultrasound systems to image the upper airway has been limited because the air column attenuates ultrasound energy. A computer-controlled bidirectional ultrasound system combines two conventional ultrasound devices with computer image processing to yield images of upper airway structures.
Submental ultrasonography of neck can be used to assess tongue base thickness, subcutaneous fat thickness, palatal thickness, retropalatal diameter, retroglossal diameter and upper airway length during normal tidal expiration, forced inspiration, and Muller’s maneuver (Fig.21.17).
21 Radiological Diagnosis inOSA
https://t.me/medicina_free
389
Fig. 21.17 Submental USG image of upper airway in various position
390
https://t.me/medicina_free
V. K. Paramasivan et al.
Due to the convenience, inexpensiveness, no irradiation, and ofce-based proce­dure, it can be commonly used to examine the neck in OSAS patients. USG has been used for sleep disorder patients, to evaluate the carotid intima-media thickness and level of obstruction in recent years [5456]. Lahav etal. [57] rst used a tongue base USG to measure the width of the tongue base and demonstrated the possible role of USG in diagnosing OSAS.Shu etal. [55] used the retropharyngeal diameter to determine the severity of OSA and proposed a prediction model. Chen etal. [56] veried the tongue base thickness, providing a quantitative assessment of the retro­glossal airway. These reports show a promising role for USG in diagnosing OSAS.
Take-Home Message
• Imaging the upper airway is essential for the diagnosis and treatment planning of
OSA patients because it can detect the level, degree, and causes of the upper
airway obstruction. In addition, it has a denite role in predicting treatment
response and monitoring of patients with OSAS after therapy.
• X-ray nasopharynx will help us measure the size of adenoidal hypertrophy and
document the difference after treatment. Lateral cephalometry and 3D recon-
structed imaging of facial bone are important imaging modalities when planning
for any skeletal framework surgery. Both CT and MRI can provide an excellent
evaluation of the various anatomical planes of the site of obstruction, which
enables better clinical assessment as well as better planning for a possible surgi-
cal approach. With dynamic MRI, we perform a volumetric analysis of the air-
way and the surrounding structure. Functional MRI is mainly used to analyze
cognitive function to assess the severity of OSAS and its effect on the brain. In
addition, submental USG are still in research phase where it needs further devel-
opment for routine practice.
• There are various radiological modalities of investigation available for the upper
airway assessment. We need to choose the right examination for our patient.
Sometimes, more than one investigation may be needed, and they may be com-
plimentary to each other.
References
1. Suto Y, Matsuo T, Kato T, Hori I, Inoue Y, Ogawa S, etal. Evaluation of the pharyngeal air­way in patients with sleep apnea: value of ultrafast MR imaging. AJR Am J Roentgenol. 1993;160(2):311–4.
2. Cohen J.A coefcient of agreement for nominal scales. Educ Psychol Measure. 1960;20:37–47.
3. Battagel JM, L'Estrange PR.The cephalometric morphology of patients with obstructive sleep apnoea (OSA). Eur J Orthod. 1996;18:557–69.
4. Bacon WH, Turlot JC, Krieger J, Stierle JL.Cephalometric evaluation of pharyngeal obstruc­tive factors in patients with sleep apneas syndrome. Angle Orthod. 1990;60:115–22.
5. Tangugsorn V, Skatvedt O, Krogstad O, Lyberg T.Obstructive sleep apnoea: a cephalometric study. Part I.Cervico-craniofacial skeletal morphology. Eur J Orthod. 1995;17:45–56.
6. Tangugsorn V, Krogstad O, Espeland L, Lyberg T.Obstructive sleep apnea (OSA): a cephalo­metric analysis of severe and non-severe OSA patients. Part I: multiple comparison of cepha­lometric variables. Int J Adult Orthodon Orthognath Surg. 2000;15:139–52.
21 Radiological Diagnosis inOSA
https://t.me/medicina_free
7. Enache AM, Nimigean VR, Mihălţan F, Didilescu AC, Munteanu I, Nimigean V.Assessment of sagittal and vertical skeletal patterns in Romanian patients with obstructive sleep apnea. Roman J Morphol Embryol. 2010;51:505–8.
8. Abramson Z, Susarla S, August M, Troulis M, Kaban L.Three-dimensional computed tomo­graphic analysis of airway anatomy in patients with obstructive sleep apnea. J Oral Maxillofac Surg. 2010;68:354–62.
9. Barrera JE, Pau CY, Forest VI, Holbrook AB, Popelka GR.Anatomic measures of upper air­way structures in obstructive sleep apnea. World J Otol Head Neck Surg. 2017;3:85–91.
10. Mozzo P, Procacci C, Tacconi A, Martini PT, Andreis IA.A new volumetric CT machine for dental imaging based on the cone-beam technique: preliminary results. Eur Radiol. 1998;8:1558–64.
11. Ludlow JB, Ivanovic M. Comparative dosimetry of dental CBCT devices and 64-slice CT for oral and maxillofacial radiology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:106–14.
12. Scarfe WC, Farman AG, Sukovic P.Clinical applications of cone-beam computed tomography in dental practice. J Can Dent Assoc. 2006;72(1):75.
13. Enciso R, Nguyen M, Shigeta Y, Ogawa T, Clark GT.Comparison of cone-beam CT param­eters and sleep questionnaires in sleep apnea patients and control subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:285–93.
14. Mayer P, Pepin JL, Bettega G, Veale D, Ferretti G, Deschaux C, et al. Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients. Eur Respir J. 1996;9:1801–9.
15. Ogawa T, Enciso R, Shintaku WH, Clark GT. Evaluation of cross-section airway con­guration of obstructive sleep apnea. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:102–8.
16. Alsufyani NA, Al-Saleh MA, Major PW.CBCT assessment of upper airway changes and treat­ment outcomes of obstructive sleep apnoea: a systematic review. Sleep Breath. 2013;17:911–23.
17. Camacho M, Capasso R, Schendel S.Airway changes in obstructive sleep apnoea patients associated with a supine versus an upright position examined using cone beam computed tomography. J Laryngol Otol. 2014;128:824–30.
18. Aboelmaaty W, Isaac M, Elsobky A, Elewa M.Cone beam computed tomography role in surgi­cal treatment planning of obstructive sleep apnea patients. Egypt Dent J. 2018;64(3):2355–60.
https://doi.org/10.21608/edj.2018.76812.
19. Barrera JE, Holbrook AB, Santos J, Popelka GR.Sleep MRI: novel technique to identify air­way obstruction in obstructive sleep apnea. Otolaryngol Head Neck Surg. 2009;140:423–5.
20. Donnelly LF, Surdulescu V, Chini BA, Casper KA, Poe SA, Amin RS.Upper airway motion depicted at cine MR imaging performed during sleep: comparison between young patients with and those without obstructive sleep apnea. Radiology. 2003;227:239–45.
21. Shott SR, Donnelly LF.Cine magnetic resonance imaging: evaluation of persistent airway obstruction after tonsil and adenoidectomy in children with down syndrome. Laryngoscope. 2004;114:1724–9.
22. Strauss R, Burgoyne C. Diagnostic imaging and sleep medicine. Dent Clin N Am. 2008;52:891–915.
23. Junior C, Filho H, Gomes C, etal. Radiological ndings in patients with obstructive sleep apnea. J Bras Pneumol. 2013;39:98–101.
24. Zhang Y, Yang X, Hua H, etal. Comparison of MRI fast SPGR single slice scan and continu­ous dynamic scan in patients with obstructive sleep apnea-hypopnea syndrome. Eur J Radiol. 2009;71:17–21.
25. Barrera JE.Sleep magnetic resonance imaging: dynamic characteristics of the airway during sleep in obstructive sleep apnea syndrome. Laryngoscope. 2011;121:1327–35.
26. Shin LK, Holbrook AB, Capasso R, etal. Improved sleep MRI at 3 Tesla in patients with obstructive sleep apnea. J Magn Reson Imaging. 2013;38:1261–6.
27. Laya B, Lee E.Congenital causes of upper airway obstruction in pediatric patients: updated imaging techniques and review of imaging ndings. Semin Roentgenol. 2012;47:147–58.
391
392
https://t.me/medicina_free
28. Donnelly L.Magnetic resonance sleep studies in the evaluation of children with obstructive sleep apnea. Semin Ultrasound CT MRI. 2010;31:107–15.
29. Simon S, Collop N. Latest advances in sleep medicine: obstructive sleep apnea. Chest. 2012;142:1645–51.
30. Kendzerska T, Mollayeva T, Gershon AS, etal. Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review. Sleep Med Rev. 2014;18:49–59.
31. Mannarino M, Di Filippo F, Pirro M.Obstructive sleep apnea syndrome. Eur J Intern Med. 2012;23:586–93.
32. Song CM, Lee CH, Rhee CS, etal. Analysis of genetic expression in the soft palate of patients with obstructive sleep apnea. Acta Otolaryngol. 2012;132(Suppl 1):S63–8.
33. Sedaghat A, Flax-Goldenberg R, Gayler B, etal. A case–control comparison of lingual tonsil­lar size in children with and without down syndrome. Laryngoscope. 2012;122:1165–9.
34. Fricke BL, Donnelly LF, Shott SR, etal. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006;36:518–23.
35. Donnelly LF, Strife JL, Myer CM 3rd. Glossoptosis (posterior displacement of the tongue) during sleep: a frequent cause of sleep apnea in pediatric patients referred for dynamic sleep uoroscopy. AJR Am J Roentgenol. 2000;175:1557–60.
36. Okubo M, Suzuki M, Horiuchi A, etal. Morphologic analyses of mandible and upper air­way soft tissue by MRI of patients with obstructive sleep apnea hypopnea syndrome. Sleep. 2006;29:909–15.
37. Horner RL, Mohiaddin RH, Lowell DG, etal. Sites and sizes of fat deposits around the phar­ynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J. 1989;2(7):613–22.
38. Zafereo ME Jr, Pereira KD.Chronic retropharyngeal abscess presenting as obstructive sleep apnea. Pediatr Emerg Care. 2008;24:382–4.
39. Bharadwaj R, Ravikumar A, Krishnaswamy NR.Evaluation of craniofacial morphology in patients with obstructive sleep apnea using lateral cephalometry and dynamic MRI.Indian J Dent Res. 2011;22:739–48.
40. Chi L, Comyn FL, Mitra N, etal. Identication of craniofacial risk factors for obstructive sleep apnoea using three-dimensional MRI.Eur Respir J. 2011;38:348–58.
41. De Miguel-Diez J, Alvarez-Sala JL, Villa-Asensi JR.Magnetic resonance imaging of the upper airway in children with down syndrome. Am J Respir Crit Care Med. 2002;165:1187.
42. Haute F, Taboada G, Correa L, et al. Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol. 2008;158:459–65.
43. Canessa N, Castronovo V, Cappa SF, etal. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–26. https://doi.org/10.1164/rccm.201005- 0693OC.
44. Castronovo V, Scifo P, Castellano A, et al. White matter integrity in obstructive sleep apnea before and after treatment. Sleep. 2014;37:1465–75.
45. Morrell MJ, Jackson ML, Twigg GL.Changes in brain morphology in patients with obstruc­tive sleep apnoea. Thorax. 2010;65:908–14.
46. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging. 2005;15:46S–57S.
47. Abbott C, Bustillo J.What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr Opin Psychiatry. 2006;19:135–9.
48. Forton DM, Allsop JM, Cox IJ, etal. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS. 2005;19:S53–63.
49. Larsson HB, Christiansen P, Jensen M, etal. Localized invivo proton spectroscopy in the brain of patients with multiple sclerosis. Magn Reson Med. 1991;22:23–31.
50. Meyerhoff DJ, MacKay S, Constans JM, etal. Axonal injury and membrane alterations in Alzheimer’s disease suggested by invivo proton magnetic resonance spectroscopic imaging. Ann Neurol. 1994;36:40–7.
V. K. Paramasivan et al.
21 Radiological Diagnosis inOSA
https://t.me/medicina_free
51. Van der Grond J, Balm R, Kappelle LJ, Eikelboom BC, Mali WP.Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery. A 1H-MR spectroscopic imag­ing study. Stroke. 1995;26:822–8.
52. Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D.Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc. 2004;10:772–85.
53. Beebe DW, Gozal D.Obstructive sleep apnea and the prefrontal cortex: towards a comprehen­sive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral decits. J Sleep Res. 2002;11:1–16.
54. Lahav Y, Rosenzweig E, Heyman Z, etal. Tongue base ultrasound: a diagnostic tool for pre­dicting obstructive sleep apnea. Ann Otol Rhinol Laryngol. 2009;118:179–84.
55. Shu CC, Lee P, Lin JW, etal. The use of sub-mental ultrasonography for identifying patients with severe obstructive sleep apnea. PLoS One. 2013;8:e62848.
56. Chen JW, Chang CH, Wang SJ, etal. Submental ultrasound measurement of dynamic tongue base thickness in patients with obstructive sleep apnea. Ultrasound Med Biol. 2014;40:2590–8.
57. Lo WC, Cheng PW, Wang CT, et al. Real-time ultrasound elastography: an assessment of enlarged cervical lymph nodes. Eur Radiol. 2013;23:2351–7.
393
Allergic Rhinitis andOSA
https://t.me/medicina_free
22
AlvaroCarvallo andGabrielGastaminza
22.1 Allergic Rhinitis
Allergic rhinitis (AR) is the most prevalent allergic disease. It affects a signicant portion of the population, with a prevalence of conrmed AR of up to 28% among European adults, a number that seems to be increasing worldwide [1]. In Spain, it is also the most frequent reason for consultation in allergy departments in both adult (62%) and pediatric (54%) populations [2, 3]. Its prevalence increases during the rst years of life. Nasal symptoms are persistent (almost 30%) during the third decade of life and lower above 60years [4]. The symptoms that most frequently establish a diagnosis of rhinitis are nasal congestion, anterior and posterior rhinor­rhea, sneezing, and nose itching. AR is frequently and characteristically accompa­nied by ocular symptoms (conjunctival erythema, epiphora or pruritus) and bronchial symptoms (cough, wheezing, and dyspnea). Other allergic diseases, such as atopic dermatitis and food allergy, are also more frequent among AR patients.
In AR, the symptoms are elicited by exposition to an allergen. For this reason, during a study of a patient with rhinitis, it is essential to carry out a complete clinical history on the temporality of the symptoms, their geographical or seasonal varia­tion, and their relationship with specic exposures. It is essential to ask about the characteristics of the home environment, the products to which the patient is exposed at work, the hobbies they may practice, or any pets they might own.
A. Carvallo (*) · G. Gastaminza Department of Allergy and Clinical Immunology, Clínica Universidad de Navarra, Pamplona, Spain e-mail: acarvallo@unav.es
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 P. M. Baptista et al. (eds.), Obstructive Sleep Apnea,
https://doi.org/10.1007/978-3-031-35225-6_22
395
396
https://t.me/medicina_free
A. Carvallo and G. Gastaminza
22.1.1 Mechanisms ofAllergic Rhinitis
Allergen exposure causes inammation of the mucosa that is part of type 2 inam­mation, which is also involved in chronic rhinosinusitis with nasal polyps (CRSwNP). This inammation is driven by Th2 lymphocytes or group 2 innate lymphoid cells (ILC2) and induced by local dendritic cells. Typical cytokines involved are IL-4, IL-5 and IL-13. IL-4 induces the production of local immuno­globulin E (IgE) antibodies (specic to the allergen in AR or polyclonal in the case of CRSwNP) [5, 6]. IL-5 is a potent stimulator of the recruitment and survival of eosinophils [7]. IL-13 is a signicant contributor to the development of a late nasal response and can be responsible for the persistent nasal blockage in AR [8]. A rep­resentation of this allergenic response, including type 2 inammation, can be seen in Fig.22.1.
Specic IgE to a perennial or seasonal allergen can be locally produced in the nasal mucosa, without being present in serum. In patients suffering a local AR (LAR), skin prick testing (SPT) with aeroallergens and specic IgE determination in serum yield negative results. LAR diagnosis can only be conrmed with a nasal challenge test. Most of these patients are monosensitized to a single allergen, but almost 40% of them are polysensitized [9]. In addition, some patients suffering symptoms of perennial rhinitis have positive SPT to seasonal allergens only. These patients can be labeled as mixed rhinitis (coexistence of AR and NAR) or dual AR (coexistence of AR and LAR). In these patients, with discordance between clinical history and SPT results, accurate diagnosis can only be established with a nasal
Fig. 22.1 Mechanisms of type 2 inammation in the upper airway epithelium
22 Allergic Rhinitis andOSA
https://t.me/medicina_free
397
challenge test or by performing an invitro challenge test with the patient’s baso­phils, the Basophil Activation Test (BAT) [10].
22.1.2 Clinical Relevance inAllergy Diagnosis
Sensitization to an allergen is not equal to allergy. Clinical relevance is required to label a patient as allergic, which means there must be congruence between clinical history and the results obtained by allergy tests. Not every sensitization found on allergy tests elicits symptoms and thus does not always equal allergy. Therefore, careful interpreta­tion of allergy tests, positive or negative, is required to perform an accurate diagnosis. When no clinically relevant allergens are identied, a diagnosis of non-allergic rhinitis (NAR) can be established. When exposition to the allergen is continuous, as is the case with house dust mites and pets, the relationship between symptom onset and contact with the allergen can be lost. For this reason, some patients are sensitized to dust mites or other non-seasonal allergens that do not have the suspicion that their symptoms might be allergy related. In these cases, the main symptom is usually nasal congestion. Table22.1 shows the main allergens that commonly cause respiratory allergies.
Table 22.1 Main allergens causing respiratory allergy
House dust and storage mites
Pets Cat
Grass pollen Lolium perenne
Tree pollen Cupressus arizonica
Weed pollen Parietaria judaica
Molds Alternaria alternata
Other allergens Natural rubber latex
Dermatophagoides pteronyssinus Dermatophagoides pharinae Lepidogliphus destructor Blomia tropicalis Tyrophagus putrescentiae Acarus siro
Dog Rodent
Phleum pratense
Olea europaea Platanus acerifolia Betula verrucosa
Plantago lanceolata Ambrosia elatior Chenopodium album Salsola kali Artemisia vulgaris
Cladosporium herbarum Aspergillus fumigatus Penicillium notatum
Ispaghula Horse Cockroach
398
https://t.me/medicina_free
A problem that allergy specialists must deal with frequently is a low degree sen­sitization to a perennial allergen, usually to house dust mites. In these cases, doubts arise about the clinical relevance of this sensitization. The rst option to elucidate this problem would be to conduct a nasal provocation test with a mite extract. However, this test needs to be standardized, is time-consuming, and may sometimes be unavailable. Another possibility, as mentioned above, is to perform a BAT.In this test, basophils are isolated from the patient’s blood and incubated invitro with the mite extract; subsequently, the percentage of basophils that have been activated (dened as expressing protein CD63in their membrane) with different concentra­tions of the extract is measured, obtaining a dose/response curve [10]. Another help­ful method would be the determination of specic IgE to recombinant allergens. Finally, the presence of sensitization to certain mite allergens (Der p7 and Der p23) has been more frequently associated with the presence of allergic symptoms after exposure to mites [11].
Clinical Relevance
A allergy diagnosis requires three elements: a symptom suggestive of allergy,
a proven sensitization to an allergen, and clinical relevance between the rst
two elements. Careful interpretation of allergy test results is paramount to
performing an accurate diagnosis.
A. Carvallo and G. Gastaminza
22.2 Rhinitis andOSA
22.2.1 General Findings
The relationship between rhinitis and OSA has been a topic of study due to their shared involvement of the upper airways. Nasal obstruction during the day, which AR patients commonly experienced by, has been identied as an independent risk factor for OSA [12]. Rhinitis symptoms are common among OSA patients, with a prevalence of 56% in this population [13]. Rhinitis not only coexists with OSA in a signicant proportion of patients but is also linked with several sleep parameters and OSA outcomes. In addition, the severity of rhinitis symptoms positively corre­lates with increased daytime sleepiness and negatively correlates with continuous positive airway pressure (CPAP) compliance [14].
22.2.2 Rhinitis andCPAP Use
The impact of rhinitis on CPAP tolerance and compliance is a matter of interest. Continuous CPAP use causes an early inammatory response of the nasal mucosa [15], which explains why rhinorrhea, nasal congestion, and sneezing are reported as side effects of CPAP [16, 17]. Neutrophils in the nasal mucosa experience a